DRG Market Assessment 보고서

With a drug-treated population of over 3.3 million in the United States, France, Germany, and the United Kingdom, the moderate to severe psoriasis market has been a lucrative space for drug…

Although the schizophrenia drug market is crowded, few, if any, effective therapies are available in the United States and Europe to treat the negative symptoms of schizophrenia (e.g., apathy,…

Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…

Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…

Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…

Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…

Clarivate Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries. We report diagnosed prevalence of vitiligo for each country, as well…

Prophylactic treatment of migraine is mainly considered for chronic migraine patients or those with episodic migraine who have long-lasting attacks or do not experience sufficient relief with acute…

Focal segmental glomerulosclerosis (FSGS) is a kidney disease in which scarring occurs to the glomeruli. Patients with FSGS typically present with nephrotic syndrome, involving edema and…

Age-related macular degeneration (AMD) is a leading cause of visual impairment in the United States, and more than half of advanced AMD patients have the wet (exudative, neovascular) form of the…

Clarivate Epidemiology’s coverage of type 1 diabetes (T1D) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and…

Clarivate Epidemiology’s coverage of type 1 diabetes (T1D) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and…